Arcus Biosciences Inc (RCUS)

Exchange
NYSE
Symbol
RCUS
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States. The company is headquartered in Hayward, California.
Country
USA

Stock price

At close: June 20, 2025

  • Open
    8.58
  • High
    8.74
  • Low
    8.31
  • Close
    8.62
  • Volume
    1,325,220

Financial ratios

Dec 31, 2024